Literature DB >> 22339683

Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy.

Gábor Cserni1.   

Abstract

Two cases of apocrine papillary lesions are presented, in which myoepithelial cells were not visualized on hematoxylin and eosin-stained slides. A complex sclerosing papillary lesion did not exhibit myoepithelial cells on p63 and CD10 immunostaining, although a thin rim of myoepithelial cell cytoplasm was revealed by smooth muscle actin, calponin, and S100 immunostains. In the other lesion, without sclerosis, myoepithelium was not detected in the central papillary cores or at the periphery of the cystic wall on hematoxylin and eosin-stained sections or with any of the myoepithelial markers tested, although two small wall areas did display the presence of myoepithelium. These two cases strengthen the view that the lack of myoepithelium alone in apocrine lesions cannot be equated with malignancy. As recent literature reports have demonstrated that myoepithelial cells may be missing from benign apocrine changes and proliferations of different types, a reconsideration of the diagnostic criteria of the malignancy of such lesions appears essential.
© 2011 The Author. APMIS © 2011 APMIS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22339683     DOI: 10.1111/j.1600-0463.2011.02840.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers.

Authors:  G Cserni; C A Wells; H Kaya; P Regitnig; A Sapino; G Floris; T Decker; M P Foschini; P J van Diest; D Grabau; A Reiner; J DeGaetano; E Chmielik; A Cordoba; X Andreu; V Zolota; E Charafe-Jauffret; A Ryska; Z Varga; N Weingertner; J P Bellocq; I Liepniece-Karele; G Callagy; J Kulka; H Bürger; P Figueiredo; J Wesseling; I Amendoeira; D Faverly; C M Quinn; S Bianchi
Journal:  Virchows Arch       Date:  2016-01-27       Impact factor: 4.064

2.  Multiplex PCR analysis of apocrine lesions shows frequent PI3K-AKT pathway mutations in both benign and malignant apocrine breast tumors.

Authors:  Naoki Kanomata; Rin Yamaguchi; Junichi Kurebayashi; Takuya Moriya
Journal:  Med Mol Morphol       Date:  2019-05-28       Impact factor: 2.309

Review 3.  Apocrine lesions of the breast.

Authors:  Cecily M Quinn; Clare D'Arcy; Clive Wells
Journal:  Virchows Arch       Date:  2021-09-18       Impact factor: 4.535

4.  Selective ductectomy for the diagnosis and treatment of intraductal papillary lesions presenting with single duct discharge.

Authors:  R Maráz; G Boross; E Ambrózay; M Svébis; G Cserni
Journal:  Pathol Oncol Res       Date:  2013-03-24       Impact factor: 3.201

5.  Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.

Authors:  Tanya D Russell; Sonali Jindal; Samiat Agunbiade; Dexiang Gao; Megan Troxell; Virginia F Borges; Pepper Schedin
Journal:  Am J Pathol       Date:  2015-09-04       Impact factor: 4.307

Review 6.  Papillary lesions of the breast.

Authors:  Janina Kulka; Lilla Madaras; Giuseppe Floris; Sigurd F Lax
Journal:  Virchows Arch       Date:  2021-11-03       Impact factor: 4.535

7.  Apocrine Encapsulated Papillary Carcinoma of the Breast: The First Reported Case with an Infiltrative Component.

Authors:  Bence Kővári; Katalin Ormándi; Zsolt Simonka; András Vörös; Gábor Cserni
Journal:  J Breast Cancer       Date:  2018-06-20       Impact factor: 3.588

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.